- Voyager Therapeutics ( NASDAQ: VYGR ) is scheduled to announce Q3 earnings results on Tuesday, November 8th, before market open.
- The consensus EPS Estimate is -$0.43 (+35.8% Y/Y) and the consensus Revenue Estimate is $9.03M (+510.1% Y/Y).
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 1 downward. Revenue estimates have seen 1 upward revision and 3 downward.
- Over the last 2 years, VYGR has beaten EPS estimates 50% of the time and has beaten revenue estimates 25% of the time.
For further details see:
Voyager Therapeutics Q3 2022 Earnings Preview